UPDATED Jun 02, 2023
U.S. Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
PHMPharma Mar | €33.64 | -2.4% | -52.2% | €609.1m | €61.37 | PE21.2x | E28.5% | 1.9% | Pharmaceuticals & Biotech | ||
ITXIndustria de Diseño Textil | €32.15 | 3.3% | 45.7% | €100.1b | €32.30 | PE24.2x | E7.2% | 3.7% | Retail | ||
ECRErcros | €3.38 | -2.2% | -3.0% | €318.0m | n/a | PE4.9x | E-9.5% | 4.4% | Materials | ||
NTHNaturhouse Health | €1.75 | 1.2% | -2.0% | €104.9m | n/a | PE10.9x | E-0.3% | 5.7% | Retail | ||
VIDVidrala | €90.00 | 1.6% | 27.5% | €2.8b | €101.19 | PE18x | E10.7% | 1.3% | Materials | ||
AGILAgile Content | €3.84 | 2.7% | -31.9% | €88.5m | €9.00 | PB2.2x | E36.6% | n/a | Software | ||
ENCENCE EnergÃa y Celulosa | €2.95 | -2.6% | -18.5% | €716.1m | €4.41 | PE2.7x | E-12.8% | 19.1% | Materials | ||
IBGIberpapel Gestión | €16.15 | -0.6% | 2.9% | €175.7m | €19.70 | PE11.1x | E3.3% | 1.9% | Materials | ||
ORYOryzon Genomics | €2.08 | 1.5% | -14.2% | €115.0m | €11.50 | PS7.2x | E69.4% | n/a | Pharmaceuticals & Biotech | ||
GRIGriñó Ecologic | €1.68 | 0% | -20.0% | €51.1m | n/a | PE24.7x | n/a | n/a | Commercial Services | ||
GSJGrupo Empresarial San José | €3.90 | -0.8% | -10.7% | €253.6m | €9.65 | PE13.7x | S0.06% | 2.6% | Capital Goods | ||
REPRepsol | €13.37 | 2.3% | -11.8% | €17.7b | €17.14 | PE4.5x | E-16.9% | 5.6% | Energy | ||
A3MAtresmedia Corporación de Medios de Comunicación | €3.61 | 1.5% | -8.6% | €812.9m | €3.84 | PE7.2x | E-2.1% | 11.1% | Media | ||
NEANicolás Correa | €5.65 | 0.9% | 6.6% | €68.3m | €8.10 | PE7.6x | S-4.3% | 4.1% | Capital Goods | ||
COMCatenon | €1.42 | 0.7% | -30.0% | €26.0m | €2.50 | PE13.6x | S25.4% | n/a | Commercial Services | ||
HOMENeinor Homes | €9.00 | 0.8% | -21.6% | €669.0m | €11.29 | PE6.9x | E-10.8% | 6.9% | Consumer Durables | ||
CBAVClÃnica Baviera | €18.15 | -5.0% | -22.4% | €295.9m | n/a | PE10x | n/a | 7.2% | Healthcare | ||
FAEFaes Farma | €3.36 | -0.1% | -15.2% | €1.0b | €3.85 | PE11.4x | E1.1% | 4.6% | Pharmaceuticals & Biotech | ||
IDRIndra Sistemas | €11.67 | 0.8% | 9.6% | €2.1b | €14.10 | PE11.7x | E8.3% | 2.1% | Software | ||
ROVILaboratorios Farmaceuticos Rovi | €41.86 | -5.9% | -32.0% | €2.2b | €57.29 | PE11.5x | E10.9% | 3.1% | Pharmaceuticals & Biotech | ||
YINB6Inbest Prime VI Inmuebles | €1.06 | 0% | 11.0% | €43.5m | n/a | PB1.1x | n/a | 2.6% | Real Estate | ||
MCMMiquel y Costas & Miquel | €11.80 | -4.5% | -8.8% | €454.2m | n/a | PE14.4x | n/a | 4.0% | Materials | ||
TL5Mediaset España Comunicación | €2.89 | -7.7% | -31.3% | €905.1m | €4.08 | PE5.1x | E-3.2% | 0% | Media | ||
LLYCLlorente & Cuenca | €10.60 | -2.8% | -8.6% | €123.3m | n/a | PE17.7x | E17.3% | n/a | Media |